Amends the Medical Practice Act of 1987 to allow labels on mifepristone, misoprostol, or generic alternatives to include the name of the dispensing.
The bill amends the Medical Practice Act of 1987 to modify labeling requirements for certain drugs. Specifically, it allows the label on a box, bottle, vessel, or package containing mifepristone, misoprostol, or any generic alternative to include the name of the dispensing health care practice instead of the name of the person dispensing the drug or medicine. This change is intended to provide more flexibility in labeling practices while ensuring that essential information remains on the label.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.